151. Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India
- Author
-
Akshay B. Jain
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,India ,030209 endocrinology & metabolism ,Type 2 diabetes ,Hypoglycemia ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Diabetes mellitus ,Interim ,Internal Medicine ,medicine ,Humans ,Hypoglycemic Agents ,030212 general & internal medicine ,Retrospective Studies ,Glycemic ,Glycated Hemoglobin ,Continuous glucose monitoring ,business.industry ,Blood Glucose Self-Monitoring ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Interim analysis ,Diabetes Mellitus, Type 2 ,Emergency medicine ,Female ,business ,Biomarkers ,Follow-Up Studies - Abstract
To assess the efficacy of a novel interim intervention technique using retrospective, blinded, professional continuous glucose monitoring system (pro CGM) with the Freestyle Libre Pro system over a 14-day single sensor wear-period.A retrospective analysis comprised of 105 consecutive adults at single centre in India with Type 2 diabetes, HbA1c 53 mmol/mol (7%), on non-insulin divabetes agents and/or insulin. The interim intervention technique included three visits over 14 days: Visit 1, sensor placed and patients asked to keep a food log while on pro-CGM; Visit 2 (within 1 week), interim assessment of pro CGM and diet or pharmacotherapy modifications made accordingly; Visit 3 at day 14, pro CGM re-evaluated to assess glycemic control. Glucose target range was set at 70-180 mg/dL. Analyses included prepost daily average glucose, time in range, time above range, and time below range.Average time for interim analysis was 5 days after pro CGM initiation. At Visit 3, daily average glucose decreased from 191.3 mg/dL at baseline to 137.4 mg/dL (p 0.001). Time in range improved from 42.2% to 80.2% (p 0.001). Time above range decreased from 52.1% to 18.3% (p 0.001), with a concurrent decrease in time below range from 5.7% to 1.5% (p 0.001). Recurrent hypoglycemia was detected in 27 (25.7%) individuals, whose average baseline time below range reduced from 21.1% to 1.9% (p 0.001).The interim intervention technique is a cost effective and efficient method for improving glucose outcomes through lifestyle and pharmacotherapy modifications and while utilizing a single pro-CGM sensor.Wockhardt Hospital, Mumbai, India. CLINICAL REGISTRATION: not applicable due to retrospective chart review study design.
- Published
- 2021
- Full Text
- View/download PDF